Janus Henderson Group’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-9,972
| Closed | -$231K | – | 2527 |
|
|
2024
Q3 | $231K | Hold |
9,972
| – | – | ﹤0.01% | 2378 |
|
|
2024
Q2 | $242K | Sell |
9,972
-126
| -1% | -$3.06K | ﹤0.01% | 2313 |
|
|
2024
Q1 | $340K | Buy |
10,098
+1
| +0% | +$34 | ﹤0.01% | 2179 |
|
|
2023
Q4 | $318K | Sell |
10,097
-19
| -0.2% | -$599 | ﹤0.01% | 2211 |
|
|
2023
Q3 | $258K | Buy |
10,116
+9
| +0.1% | +$230 | ﹤0.01% | 2262 |
|
|
2023
Q2 | $290K | Sell |
10,107
-13
| -0.1% | -$373 | ﹤0.01% | 2263 |
|
|
2023
Q1 | $242K | Buy |
+10,120
| New | +$242K | ﹤0.01% | 2388 |
|
|
2020
Q4 | – | Sell |
-483,078
| Closed | -$20.7M | – | 1382 |
|
|
2020
Q3 | $20.7M | Buy |
483,078
+337,270
| +231% | +$14.5M | 0.01% | 700 |
|
|
2020
Q2 | $6.81M | Buy |
+145,808
| New | +$6.81M | ﹤0.01% | 877 |
|